MUTABOR

Mutabor is a protein engineering company that utilizes a proprietary directed evolution platform to develop optimized proteins for therapeutic and industrial use. The company's technology integrates high-throughput screening with microfluidics, allowing for the rapid testing of millions of protein variants to find those with superior activity, stability, and specificity. By navigating the complex fitness landscapes of proteins more effectively than traditional methods, Mutabor aims to shorten development timelines for novel biologics. The firm's expertise spans across various modalities, including enzymes and therapeutic proteins, positioning it as a key player in the next generation of molecular design. Based in San Francisco, Mutabor was part of the Y Combinator Summer 2021 cohort and continues to advance its platform for diverse biotechnology applications.